13F-HR filed by BAKER BROS. ADVISORS LP
BAKER BROS. ADVISORS LP filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 114 holding rows worth $22,670,991,000.
- Accession
- 0001104659-20-095518
- Filer
- CIK 1263508
- Filed
- 2020-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2020
A holdings report, 114 entries on the cover page, a total value of $22,670,991,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $22,670,991,000 with VALUE read as thousands by filing date, 13F file number 028-10519. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SEATTLE GENETICS INC | 812578102 | COM | 47,269,424 | $8,032,021,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 31,999,081 | $3,326,944,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 11,777,285 | $2,218,840,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 41,904,586 | $2,031,115,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 8,760,794 | $983,312,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 7,589,294 | $936,064,000 | thousands by filing date | |
| KODIAK SCIENCES INC | 50015M109 | COM | 11,574,538 | $626,414,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 3,390,270 | $501,421,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 11,850,962 | $358,966,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 3,164,234 | $305,728,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 34,496,685 | $238,717,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 1,019,557 | $229,635,000 | thousands by filing date | |
| IGM BIOSCIENCES INC | 449585108 | COM | 3,144,223 | $229,528,000 | thousands by filing date | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 1,499,212 | $169,786,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,409,784 | $160,955,000 | thousands by filing date | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 1,846,139 | $160,503,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 906,986 | $110,652,000 | thousands by filing date | |
| PRINCIPIA BIOPHARMA INC | 74257L108 | COM | 1,580,873 | $94,520,000 | thousands by filing date | |
| FORMA THERAPEUTICS HLDGS INC | 34633R104 | SHS | 2,000,000 | $92,980,000 | thousands by filing date | |
| CERUS CORP | 157085101 | COM | 13,713,195 | $90,507,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 6,018,104 | $88,526,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 3,025,384 | $83,319,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 1,009,757 | $83,083,000 | thousands by filing date | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 1,687,500 | $78,992,000 | thousands by filing date | |
| ATRECA INC | 04965G109 | COM | 3,532,760 | $75,177,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 2,799,577 | $71,333,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 6,675,181 | $66,819,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 13,766,405 | $65,597,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 14,614,264 | $64,157,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 1,708,472 | $61,625,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 2,700,055 | $60,211,000 | thousands by filing date | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 3,397,740 | $56,402,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 945,221 | $54,388,000 | thousands by filing date | |
| ALLAKOS INC | 01671P100 | COM | 735,469 | $52,851,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125CAD1 | NOTE 2.250% 5/1 | 30,770,000 | $51,144,000 | thousands by filing date | principal |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 4,379,592 | $40,511,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 1,541,618 | $35,951,000 | thousands by filing date | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 817,631 | $33,866,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 1,911,446 | $33,756,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 2,037,469 | $32,783,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 896,551 | $29,281,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 1,701,929 | $27,656,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 1,244,744 | $24,154,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 185,045 | $22,709,000 | thousands by filing date | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 2,107,600 | $22,572,000 | thousands by filing date | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 463,539 | $22,426,000 | thousands by filing date | |
| FREQUENCY THERAPEUTICS INC | 35803L108 | COM | 945,719 | $21,988,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 787,582 | $21,643,000 | thousands by filing date | |
| NOVAVAX INC | 670002401 | COM NEW | 241,376 | $20,119,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061GAH4 | NOTE 0.599% 8/0 | 15,000,000 | $18,340,000 | thousands by filing date | principal |
| BLUEBIRD BIO INC | 09609G100 | COM | 265,000 | $16,176,000 | thousands by filing date | |
| VAXART INC NEW | 92243A200 | COM | 1,639,121 | $14,506,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 428,120 | $13,867,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 330,000 | $11,695,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 513,677 | $11,476,000 | thousands by filing date | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 583,333 | $11,352,000 | thousands by filing date | |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 673,908 | $11,261,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 200,000 | $11,116,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 230,883 | $10,404,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 799,102 | $10,021,000 | thousands by filing date | |
| UROVANT SCIENCES | G9381B108 | COMMON STOCK | 1,000,000 | $9,840,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 369,047 | $9,776,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 81,976 | $9,137,000 | thousands by filing date | |
| FULGENT GENETICS INC | 359664109 | COM | 569,444 | $9,111,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 999,823 | $8,958,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 55,983 | $8,734,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 1,635,501 | $8,341,000 | thousands by filing date | |
| IDERA PHARMACEUTICALS INC | 45168K405 | COM PAR | 4,608,786 | $8,250,000 | thousands by filing date | |
| HOOKIPA PHARMA INC | 43906K100 | COM | 700,481 | $8,140,000 | thousands by filing date | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 485,624 | $7,785,000 | thousands by filing date | |
| PASSAGE BIO INC | 702712100 | COM | 275,000 | $7,516,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 690,167 | $7,357,000 | thousands by filing date | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 636,363 | $7,089,000 | thousands by filing date | |
| ALECTOR INC | 014442107 | COMMON STOCK | 280,000 | $6,843,000 | thousands by filing date | |
| BURNING ROCK BIOTECH LTD | 12233L107 | SPONSORED ADS | 250,000 | $6,753,000 | thousands by filing date | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 199,671 | $5,854,000 | thousands by filing date | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 135,000 | $5,746,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 317,857 | $5,569,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,522,792 | $5,315,000 | thousands by filing date | |
| CHIASMA INC | 16706W102 | COM | 946,701 | $5,093,000 | thousands by filing date | |
| Inflarx Nv | N44821101 | COM | 1,058,555 | $4,859,000 | thousands by filing date | |
| ABEONA THERAPEUTICS INC | 00289Y107 | COM | 1,590,686 | $4,637,000 | thousands by filing date | |
| EVOFEM BIOSCIENCES INC | 30048L104 | COM | 1,425,000 | $4,033,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 133,333 | $4,007,000 | thousands by filing date | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 458,253 | $3,377,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 600,000 | $3,108,000 | thousands by filing date | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 425,000 | $3,064,000 | thousands by filing date | |
| GAMIDA CELL LTD | M47364100 | SHS | 666,666 | $3,047,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 119,335 | $3,031,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 121,534 | $3,007,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 47,000 | $2,967,000 | thousands by filing date | |
| Aravive Inc | 03890D108 | Common / Ordinary Stock | 244,055 | $2,841,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 128,538 | $2,702,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 13,072 | $2,579,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 27,000 | $2,572,000 | thousands by filing date | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 104,900 | $2,536,000 | thousands by filing date | |
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 124,400 | $2,456,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 405,702 | $2,434,000 | thousands by filing date | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 65,934 | $2,384,000 | thousands by filing date | |
| ARYA SCIENCES ACQUISITION CORP SHS CL A | G3165V109 | COM | 150,000 | $2,361,000 | thousands by filing date | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 500,000 | $2,310,000 | thousands by filing date | |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 158,217 | $2,182,000 | thousands by filing date | |
| OYSTER POINT PHARMA INC | 69242L106 | COMMON STOCK | 71,428 | $2,063,000 | thousands by filing date | |
| LEAP THERAPEUTICS INC | 52187K101 | COM | 978,454 | $2,045,000 | thousands by filing date | |
| BELLICUM PHARMACEUTICALS INC COM NEW | 079481404 | Stock | 249,123 | $1,851,000 | thousands by filing date | |
| MATINAS BIOPHARMA HLDGS INC | 576810105 | COM | 2,096,375 | $1,620,000 | thousands by filing date | |
| GALMED PHARMACEUTICALS LTD | M47238106 | SHS | 215,594 | $1,031,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 200,000 | $923,000 | thousands by filing date | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 580,400 | $525,000 | thousands by filing date | |
| MARKER THERAPEUTICS INC | 57055L107 | COM | 240,505 | $498,000 | thousands by filing date | |
| ADAMAS PHARMACEUTICALS INC | 00548A106 | COM | 172,630 | $442,000 | thousands by filing date | |
| GENFIT S A | 372279109 | ADS | 28,396 | $156,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328700 | COM | 556,665 | $147,000 | thousands by filing date | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 5,141 | $128,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-20-095518 | this filing | 2020-08-14 | acceptance time not in the bulk data set |